Concurrent Use of Adderall and Dexmethylphenidate

Pharmacological Considerations

Both Adderall and dexmethylphenidate are psychostimulant medications that work through similar mechanisms, increasing synaptic concentrations of dopamine and norepinephrine, according to the Journal of the National Comprehensive Cancer Network and Pharmacology and Therapeutics 1, 2
Adderall works through multiple mechanisms including inhibition of dopamine and norepinephrine transporters, vesicular monoamine transporter 2, and monoamine oxidase activity, as reported in Pharmacology and Therapeutics 2

Concurrent use of multiple stimulants can significantly increase the risk of serious adverse effects, including severe hypertension, psychosis, as noted by the Journal of the American Academy of Child and Adolescent Psychiatry 3
The maximum recommended daily dose of Adderall for adults is 40-50mg, and 30mg IR is already approaching this maximum, making additional stimulant use particularly risky, according to Praxis Medical Insights 4

If current treatment with Adderall 30mg IR is not providing adequate symptom control, consider optimizing the current Adderall dosing or switching to a different stimulant formulation, as suggested by Praxis Medical Insights 4, 5

If a medication change is implemented, careful monitoring is essential, including regular checks of blood pressure and pulse, and monitoring for signs of excessive stimulation, as recommended by Pharmacology and Therapeutics and Praxis Medical Insights 2, 4

Adding a second stimulant when the first is ineffective rather than optimizing the dose or switching medications completely, as cautioned by Praxis Medical Insights 4, 5
The American Academy of Child and Adolescent Psychiatry recommends that when maximum doses of one stimulant are ineffective, adding another stimulant is not the recommended approach, instead completely switching medications or considering non-stimulant alternatives would be safer and more appropriate 3